These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 26759826

  • 21. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group.
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [Abstract] [Full Text] [Related]

  • 22. Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.
    Hunt KJ, Baker N, Cleary P, Backlund JY, Lyons T, Jenkins A, Virella G, Lopes-Virella MF, DCCT/EDIC Research Group.
    Atherosclerosis; 2013 Dec; 231(2):315-22. PubMed ID: 24267245
    [Abstract] [Full Text] [Related]

  • 23. Plasma Prekallikrein Is Associated With Carotid Intima-Media Thickness in Type 1 Diabetes.
    Jaffa MA, Luttrell D, Schmaier AH, Klein RL, Lopes-Virella M, Luttrell LM, Jaffa AA, DCCT/EDIC Research Group.
    Diabetes; 2016 Feb; 65(2):498-502. PubMed ID: 26603531
    [Abstract] [Full Text] [Related]

  • 24. Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).
    Miller RG, Costacou T, Orchard TJ.
    Diabetes; 2019 Feb; 68(2):409-419. PubMed ID: 30409781
    [Abstract] [Full Text] [Related]

  • 25. Association of adolescent lipoprotein subclass profile with carotid intima-media thickness and comparison to adults: Prospective population-based cohort studies.
    Pechlaner R, Friedrich N, Staudt A, Gande N, Bernar B, Stock K, Kiechl SJ, Hochmayr C, Griesmacher A, Petersmann A, Budde K, Stuppner H, Sturm S, Dörr M, Schminke U, Cannet C, Fang F, Schäfer H, Spraul M, Geiger R, Mayr M, Nauck M, Kiechl S, Kiechl-Kohlendorfer U, Knoflach M, Early Vascular Ageing (EVA) Study Group.
    Atherosclerosis; 2022 Jan; 341():34-42. PubMed ID: 34995985
    [Abstract] [Full Text] [Related]

  • 26. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler AJ, Brown WV, Lyons TJ, Garvey WT, DCCT/EDIC Research Group.
    Metabolism; 2004 Oct; 53(10):1296-304. PubMed ID: 15375785
    [Abstract] [Full Text] [Related]

  • 27. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.
    Lopes-Virella MF, Carter RE, Gilbert GE, Klein RL, Jaffa M, Jenkins AJ, Lyons TJ, Garvey WT, Virella G, Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort Study Group.
    Diabetes Care; 2008 Oct; 31(10):2006-12. PubMed ID: 18628568
    [Abstract] [Full Text] [Related]

  • 28. Relation between carotid intima-media thickness and left ventricular mass in type 1 diabetes mellitus (from the Epidemiology of Diabetes Interventions and Complications [EDIC] Study).
    Chahal H, Backlund JY, Cleary PA, Lachin JM, Polak JF, Lima JA, Bluemke DA, DCCT/EDIC Research Group.
    Am J Cardiol; 2012 Nov 15; 110(10):1534-40. PubMed ID: 22884107
    [Abstract] [Full Text] [Related]

  • 29. Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.
    Genuth SM, Backlund JY, Bayless M, Bluemke DA, Cleary PA, Crandall J, Lachin JM, Lima JA, Miao C, Turkbey EB, DCCT/EDIC Research Group.
    Diabetes; 2013 Oct 15; 62(10):3561-9. PubMed ID: 23520132
    [Abstract] [Full Text] [Related]

  • 30. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.
    Keshavarzi S, Braffett BH, Pop-Busui R, Orchard TJ, Soliman EZ, Lorenzi GM, Barnie A, Karger AB, Gubitosi-Klug RA, Dagogo-Jack S, Paterson AD, DCCT/EDIC Research Group.
    Diabetes Care; 2021 May 15; 44(5):1125-1132. PubMed ID: 33632724
    [Abstract] [Full Text] [Related]

  • 31. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.
    Sousa GR, Pober D, Galderisi A, Lv H, Yu L, Pereira AC, Doria A, Kosiborod M, Lipes MA.
    Circulation; 2019 Feb 05; 139(6):730-743. PubMed ID: 30586738
    [Abstract] [Full Text] [Related]

  • 32. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
    Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH, DCCT/EDIC Research Group.
    Circulation; 2009 Jun 09; 119(22):2886-93. PubMed ID: 19470886
    [Abstract] [Full Text] [Related]

  • 33. Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.
    Jarauta E, Mateo-Gallego R, Gilabert R, Plana N, Junyent M, de Groot E, Cenarro A, Masana L, Ros E, Civeira F.
    Nutr Metab Cardiovasc Dis; 2012 Jul 09; 22(7):591-7. PubMed ID: 21196102
    [Abstract] [Full Text] [Related]

  • 34. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.
    Amor AJ, Catalan M, Pérez A, Herreras Z, Pinyol M, Sala-Vila A, Cofán M, Gilabert R, Ros E, Ortega E.
    Atherosclerosis; 2016 Apr 09; 247():161-9. PubMed ID: 26921744
    [Abstract] [Full Text] [Related]

  • 35. Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort.
    Hunt KJ, Baker NL, Cleary PA, Klein R, Virella G, Lopes-Virella MF, DCCT/EDIC Group of Investigators.
    Diabetes Care; 2015 Jul 09; 38(7):1281-9. PubMed ID: 25852210
    [Abstract] [Full Text] [Related]

  • 36. Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes.
    Zhang Y, Jenkins AJ, Basu A, Stoner JA, Lopes-Virella MF, Klein RL, DCCT/EDIC Research Group, Lyons TJ.
    J Lipid Res; 2016 Feb 09; 57(2):310-7. PubMed ID: 26658239
    [Abstract] [Full Text] [Related]

  • 37. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
    Klein RL, Hunter SJ, Jenkins AJ, Zheng D, Semler AJ, Clore J, Garvey WT, DCCT/ECIC STUDY GROUP.
    Diabetes Care; 2003 May 09; 26(5):1439-48. PubMed ID: 12716802
    [Abstract] [Full Text] [Related]

  • 38. Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Nathan DM.
    Diabetologia; 2021 May 09; 64(5):1049-1058. PubMed ID: 33550441
    [Abstract] [Full Text] [Related]

  • 39. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
    Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, Genuth S, DCCT/EDIC Research Group.
    Cardiovasc Diabetol; 2015 Sep 05; 14():118. PubMed ID: 26341632
    [Abstract] [Full Text] [Related]

  • 40. Relations of lipid parameters, other variables with carotid intima-media thickness and plaque in the general Chinese adults: an observational study.
    Hou Q, Li S, Gao Y, Tian H.
    Lipids Health Dis; 2018 May 10; 17(1):107. PubMed ID: 29747638
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.